BioSpace News Archive

Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton , Executive Vice President and Chief Financial Officer will present at the 39 th Annual J.P. Morgan Healthcare Conference in San Francisco, CA , on Monday, January 11, 2021 at 10:50 a.m. (Eastern Time) . A live audio webcast of the presentatio

AdaptHealth Corp. announced that it has commenced an underwritten public offering of 7,000,000 shares of its Class A Common Stock, and certain selling stockholders intend to offer and sell an additional 1,000,000 shares of the Company’s Class A Common Stock, subject to market and other conditions.

Galapagos NV and Selvita S.A. announced that the strategic transaction in which Selvita has acquired Fidelta from Galapagos has been completed.

NGM Biopharmaceuticals, Inc., a biotechnology company focused on discovering and developing transformative therapeutics for patients, announced that it has commenced an underwritten public offering of $100,000,000 of shares of its common stock.

DTx Pharma, Inc., a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced that Arthur T. Suckow, Ph.D., Chief Executive Officer, will be presenting a company overview and participating in virtual one-on-one meetings along with Denise Bevers, Chief Operating Officer, at the 2021 Biotech Showcase from January 11th – 15th.

Syneos Health®, the only fully integrated biopharmaceutical solutions organization combining a CRO and a CCO, announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 8:20 a.m. EST.

Stoke Therapeutics to Present at the 39 th Annual J.P. Morgan Healthcare Conference

Minnesota dentists are offering free dental care for children in need on February 5 and 6, 2021.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, the Company’s Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright VIRTUAL BioConnect Conference,

Exelixis to Present at the Virtual 39 th Annual J.P. Morgan Healthcare Conference on January 11, 2021 – Presentation to be webcast on www.exelixis.com –